It appears that uplisting to the Nasdaq is good for business. Or, at least for liquidity, as per insider action that was reported on Mind Medicine (NEO: MMED) (NASDAQ: MNMD) last night. The company has seen its CEO, JR Rahn, sell off a significant portion of his holdings in the company. As per filings made … Continue reading Mind Medicine Sees CEO Sell $24.7 Million In Company Stock